NATCOPHARM Intraday Analysis...

NATCOPHARM Share Price

Open 801.00 Change Price %
High 827.75 1 Day 1.80 0.23
Low 785.00 1 Week -4.60 -0.58
Close 792.00 1 Month -26.70 -3.26
Volume 483405 1 Year -99.00 -11.11
52 Week High 1090.00
52 Week Low 671.10
NATCOPHARM Important Levels
Resistance 2 831.63
Resistance 1 815.30
Pivot 801.58
Support 1 768.70
Support 2 752.37
NSE INDIA Most Active Stocks
JPASSOCIAT 15.65 4.33%
RCOM 14.15 -0.35%
TATAMOTORS 288.65 -6.72%
ONGC 167.70 -4.39%
SBIN 268.50 2.01%
NCC 114.40 8.69%
NCC 114.40 8.69%
PCJEWELLER 188.00 -4.54%
ASHOKLEY 144.50 -0.58%
ADANIPOWER 18.90 -5.97%
More..
NSE INDIA Top Gainers Stocks
GREENFIRE 0.30 20.00%
EROSMEDIA 142.15 19.55%
SHALPAINTS 136.60 15.27%
ORTEL 18.35 11.55%
SUJANAUNI 0.50 11.11%
EON 66.10 9.98%
STINDIA 14.35 9.96%
LAKSHMIEFL 16.80 9.80%
CENTEXT 5.95 9.17%
VASWANI 13.35 8.98%
More..
NSE INDIA Top Losers Stocks
VISESHINFO 0.10 -33.33%
INGERRAND 626.25 -28.40%
RAJRAYON 0.20 -20.00%
SPYL 0.25 -16.67%
FCSSOFT 0.25 -16.67%
TDPOWERSYS 158.50 -15.24%
BIGBLOC 118.00 -13.20%
ARIES 161.90 -9.98%
MCDHOLDING 31.55 -9.34%
GET&D 331.70 -8.43%
More..

Natco Pharma Limited (NSE: NATCOPHARM)

NATCOPHARM Technical Analysis 1.5
As on 24th May 2018 NATCOPHARM Share Price closed @ 792.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 878.75 & Buy for SHORT-TERM with Stoploss of 782.61 we also expect STOCK to react on Following IMPORTANT LEVELS.
NATCOPHARM Target for May
1st Target up-side 851.45
2nd Target up-side 882.01
3rd Target up-side 912.57
1st Target down-side 764.25
2nd Target down-side 733.69
3rd Target down-side 703.13
NATCOPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 50.17 Sideways
MFI (14) MFI is 56.99 Sideways
CCI (20) CCI is 22.49 Sideways
WILLIAM %R (14) William %R is -46.61 Sideways
ADX (14) ADX is 16.36 Range Bound
PSAR Stoploss For Long Buy 751.05
10 Day Avg Volume Traded 93.75 % More then 10 Day Average Volume
NATCOPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
NATCOPHARM Address
NATCOPHARM
N/A
NATCOPHARM Latest News
Natco Pharma - Natco receives Generic Sofosbuvir (Sovaldi) approval for India   Moneycontrol.com   - 12th Mar 15
NATCO Pharma stock rises most on US court ruling   Business Today   - 11th Mar 15
Buy Natco Pharma; target of Rs 1920: ICICIdirect   Moneycontrol.com   - 11th Mar 15
UPDATE 1-India's Natco Pharma ties up with Gilead on hepatitis C drugs   Reuters   - 02nd Mar 15
Natco Pharma - Q3 results on Feb 11, 2015   Moneycontrol.com   - 30th Jan 15
Natco Pharma dips on preferential share allotment at discount   Business Standard   - 17th Dec 14
Natco Pharma CFO passes away   Hindu Business Line   - 23rd Oct 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir.)   JD Supra (press release)   - 25th Jul 14
Gilead Sciences, Inc. v. Natco Pharma Limited   Lexology (registration)   - 08th May 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir. 2014)   Patent Docs   - 29th Apr 14
Interactive Technical Analysis Chart Natco Pharma Limited ( NATCOPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Natco Pharma Limited
NATCOPHARM Business Profile
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,439.26 crore.The company has reported a consolidated sales of Rs 179.22 crore and a Net Profit of Rs 24.26 crore for the quarter ended Sep 2013.The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Nitin Jagannath Deshmukh - Director. It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.